Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Blin

Showing results (121-130 of 149) with videos related to

Pageof 15
Sort By:
Neurology|August 15, 2002
Nonmotor fluctuations in Parkinson's disease: frequent and disablingTatiana Witjas, E Kaphan, J P Azulay, et al.
European Journal of Clinical Pharmacology|January 1, 1996
Plasma concentrations and pharmacokinetics of idebenone and its metabolites following single and repeated doses in young patients with mitochondrial encephalomyopathyP Pisano, A Durand, E Autret, et al.
Human Psychopharmacology|April 21, 2006
Efficacy of etifoxine compared to lorazepam monotherapy in the treatment of patients with adjustment disorders with anxiety: a double-blind controlled study in general practiceN Nguyen, E Fakra, V Pradel, et al.
Acta Anaesthesiologica Scandinavica|November 1, 1995
Evaluation of saccadic eye movements as an objective test of recovery from anaesthesiaO Paut, J L Vercher, O Blin, et al.
European Journal of Clinical Pharmacology|January 1, 1992
Influence of food on the tyramine pressor effect during chronic moclobemide treatment of healthy volunteersC Audebert, O Blin, S Monjanel-Mouterde, et al.
Therapie|July 1, 1996
[Study methods of drugs in Alzheimer disease]B Dubois, B Stehlé, J P Lehner, et al.
Chronobiology International|March 7, 2012
Effects of dietary resveratrol on the sleep-wake cycle in the non-human primate gray mouse lemur (Microcebus murinus)F Pifferi, A Rahman, S Languille, et al.
Fundamental & Clinical Pharmacology|August 26, 1998
Fluoxetine in orthostatic hypotension of Parkinson's disease: a clinical and experimental pilot studyJ L Montastruc, M Pelat, P Verwaerde, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 1994
Naltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's diseaseO Rascol, N Fabre, O Blin, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|August 25, 2009
Meta-analytic study of the benefits and risks of treating chronic schizophrenia with risperidone or conventional neurolepticsP Bech, J C Peuskens, S R Marder, et al.
Pageof 15

Showing results (121-130 of 149) with videos related to

Sort By:
Pageof 15
Neurology|August 15, 2002
Nonmotor fluctuations in Parkinson's disease: frequent and disablingTatiana Witjas, E Kaphan, J P Azulay, et al.
European Journal of Clinical Pharmacology|January 1, 1996
Plasma concentrations and pharmacokinetics of idebenone and its metabolites following single and repeated doses in young patients with mitochondrial encephalomyopathyP Pisano, A Durand, E Autret, et al.
Human Psychopharmacology|April 21, 2006
Efficacy of etifoxine compared to lorazepam monotherapy in the treatment of patients with adjustment disorders with anxiety: a double-blind controlled study in general practiceN Nguyen, E Fakra, V Pradel, et al.
Acta Anaesthesiologica Scandinavica|November 1, 1995
Evaluation of saccadic eye movements as an objective test of recovery from anaesthesiaO Paut, J L Vercher, O Blin, et al.
European Journal of Clinical Pharmacology|January 1, 1992
Influence of food on the tyramine pressor effect during chronic moclobemide treatment of healthy volunteersC Audebert, O Blin, S Monjanel-Mouterde, et al.
Therapie|July 1, 1996
[Study methods of drugs in Alzheimer disease]B Dubois, B Stehlé, J P Lehner, et al.
Chronobiology International|March 7, 2012
Effects of dietary resveratrol on the sleep-wake cycle in the non-human primate gray mouse lemur (Microcebus murinus)F Pifferi, A Rahman, S Languille, et al.
Fundamental & Clinical Pharmacology|August 26, 1998
Fluoxetine in orthostatic hypotension of Parkinson's disease: a clinical and experimental pilot studyJ L Montastruc, M Pelat, P Verwaerde, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 1994
Naltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's diseaseO Rascol, N Fabre, O Blin, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|August 25, 2009
Meta-analytic study of the benefits and risks of treating chronic schizophrenia with risperidone or conventional neurolepticsP Bech, J C Peuskens, S R Marder, et al.
Pageof 15